Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
ImmunoPrecise Antibodies Ltd., a biotechnology company, leverages multi-omics modeling and artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes. The company also offers syngeneic cell line for immunization and screening; peptide production for subsequent antibody discovery campaign; B cell select platform, which allows for the interrogation of animal antibody repertoire; screening of the immune repertoire of rabbits and chickens and desired antibody directly from the B cells; single step hybridoma, a semi-solid media to grow mouse and rat hybridomas; and DeepDisplay, a combination of transgenic animal platform and custom IPA phage display antibody selection. In addition, it provides phage display, a custom immune library; CAR development, an adaptable antibody, which allows the inclusion of functional data early in the screening funnel; antibody sequencing; and assay development. Further, it offers a profiling toolset for antibody lead candidates; and in vitro analytical tools for the study of quality attributes. Additionally, it provides LucinaTech, an antibody humanization to identify framework and CDR residues; antibody affinity maturation for therapeutic and diagnostic application; antibody chimerization for cloning and production of antibody domain; Eurofins preclinical services; hybrid service model designed to reduce time and risk with custom applications; breadth and depth to accelerate assay development, screening cascades, drug candidate validation, and new biotherapeutic concepts; and protein manufacturing services. The company is headquartered in Victoria, Canada. more
Time Frame | IPA | Sector | S&P500 |
---|---|---|---|
1-Week Return | 9.05% | -2.82% | 0.15% |
1-Month Return | -14.87% | -4.22% | 1.78% |
3-Month Return | -37.48% | -9.52% | 8.7% |
6-Month Return | -61.9% | -3.45% | 12.24% |
1-Year Return | -63.95% | 5.62% | 30.9% |
3-Year Return | -92.09% | 3.8% | 30.19% |
5-Year Return | -78.77% | 39.68% | 91.72% |
10-Year Return | 27.02% | 105.02% | 203.2% |
Apr '20 | Apr '21 | Apr '22 | Apr '23 | Apr '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 14.06M | 17.91M | 19.36M | 20.66M | 24.52M | [{"date":"2020-04-30","value":57.34,"profit":true},{"date":"2021-04-30","value":73.06,"profit":true},{"date":"2022-04-30","value":78.98,"profit":true},{"date":"2023-04-30","value":84.29,"profit":true},{"date":"2024-04-30","value":100,"profit":true}] |
Cost of Revenue | 6.02M | 6.37M | 8.38M | 9.10M | 12.46M | [{"date":"2020-04-30","value":48.33,"profit":true},{"date":"2021-04-30","value":51.14,"profit":true},{"date":"2022-04-30","value":67.24,"profit":true},{"date":"2023-04-30","value":73.02,"profit":true},{"date":"2024-04-30","value":100,"profit":true}] |
Gross Profit | 8.03M | 11.54M | 10.98M | 11.56M | 12.05M | [{"date":"2020-04-30","value":66.66,"profit":true},{"date":"2021-04-30","value":95.73,"profit":true},{"date":"2022-04-30","value":91.12,"profit":true},{"date":"2023-04-30","value":95.93,"profit":true},{"date":"2024-04-30","value":100,"profit":true}] |
Gross Margin | 57.15% | 64.41% | 56.72% | 55.95% | 49.16% | [{"date":"2020-04-30","value":88.72,"profit":true},{"date":"2021-04-30","value":100,"profit":true},{"date":"2022-04-30","value":88.05,"profit":true},{"date":"2023-04-30","value":86.87,"profit":true},{"date":"2024-04-30","value":76.32,"profit":true}] |
Operating Expenses | 12.08M | 15.71M | 27.15M | 39.78M | 12.05M | [{"date":"2020-04-30","value":30.37,"profit":true},{"date":"2021-04-30","value":39.5,"profit":true},{"date":"2022-04-30","value":68.25,"profit":true},{"date":"2023-04-30","value":100,"profit":true},{"date":"2024-04-30","value":30.3,"profit":true}] |
Operating Income | (4.09M) | (6.65M) | (15.78M) | (26.09M) | (13.76M) | [{"date":"2020-04-30","value":-409400000,"profit":false},{"date":"2021-04-30","value":-665300000,"profit":false},{"date":"2022-04-30","value":-1578100000,"profit":false},{"date":"2023-04-30","value":-2609100000,"profit":false},{"date":"2024-04-30","value":-1376200000,"profit":false}] |
Total Non-Operating Income/Expense | (346.81K) | (2.66M) | (207.00K) | (1.90M) | (14.94M) | [{"date":"2020-04-30","value":-34680900,"profit":false},{"date":"2021-04-30","value":-265900000,"profit":false},{"date":"2022-04-30","value":-20700000,"profit":false},{"date":"2023-04-30","value":-190100000,"profit":false},{"date":"2024-04-30","value":-1493700000,"profit":false}] |
Pre-Tax Income | (5.29M) | (6.00M) | (15.85M) | (27.75M) | (28.70M) | [{"date":"2020-04-30","value":-529315400,"profit":false},{"date":"2021-04-30","value":-599500000,"profit":false},{"date":"2022-04-30","value":-1584800000,"profit":false},{"date":"2023-04-30","value":-2775200000,"profit":false},{"date":"2024-04-30","value":-2870300000,"profit":false}] |
Income Taxes | (345.73K) | 1.34M | 861.00K | (1.19M) | (1.53M) | [{"date":"2020-04-30","value":-25.7,"profit":false},{"date":"2021-04-30","value":100,"profit":true},{"date":"2022-04-30","value":64.01,"profit":true},{"date":"2023-04-30","value":-88.62,"profit":false},{"date":"2024-04-30","value":-113.46,"profit":false}] |
Income After Taxes | (4.95M) | (7.34M) | (16.71M) | (26.56M) | (27.18M) | [{"date":"2020-04-30","value":-494742600,"profit":false},{"date":"2021-04-30","value":-734000000,"profit":false},{"date":"2022-04-30","value":-1670900000,"profit":false},{"date":"2023-04-30","value":-2656000000,"profit":false},{"date":"2024-04-30","value":-2717700000,"profit":false}] |
Income From Continuous Operations | (4.95M) | (7.34M) | (16.71M) | (26.56M) | (27.18M) | [{"date":"2020-04-30","value":-494742600,"profit":false},{"date":"2021-04-30","value":-734000000,"profit":false},{"date":"2022-04-30","value":-1670900000,"profit":false},{"date":"2023-04-30","value":-2656000000,"profit":false},{"date":"2024-04-30","value":-2717700000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-04-30","value":"-","profit":true},{"date":"2021-04-30","value":"-","profit":true},{"date":"2022-04-30","value":"-","profit":true},{"date":"2023-04-30","value":"-","profit":true},{"date":"2024-04-30","value":"-","profit":true}] |
Net Income | (4.95M) | (7.34M) | (16.71M) | (26.56M) | (27.18M) | [{"date":"2020-04-30","value":-494742600,"profit":false},{"date":"2021-04-30","value":-734000000,"profit":false},{"date":"2022-04-30","value":-1670900000,"profit":false},{"date":"2023-04-30","value":-2656000000,"profit":false},{"date":"2024-04-30","value":-2717700000,"profit":false}] |
EPS (Diluted) | (0.46) | (0.40) | (0.82) | (1.08) | (0.46) | [{"date":"2020-04-30","value":-45.99,"profit":false},{"date":"2021-04-30","value":-39.71,"profit":false},{"date":"2022-04-30","value":-81.67,"profit":false},{"date":"2023-04-30","value":-108,"profit":false},{"date":"2024-04-30","value":-46,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
IPA | |
---|---|
Cash Ratio | 0.28 |
Current Ratio | 1.01 |
Quick Ratio | 0.85 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
IPA | |
---|---|
ROA (LTM) | -13.45% |
ROE (LTM) | -64.04% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
IPA | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.46 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.54 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
IPA | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.48 |
P/B | 0.50 |
Price/FCF | NM |
EV/R | 1.21 |
EV/Ebitda | NM |
Immunoprecise Antibodies Ltd (IPA) share price today is $0.4001
Yes, Indians can buy shares of Immunoprecise Antibodies Ltd (IPA) on Vested. To buy Immunoprecise Antibodies Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IPA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Immunoprecise Antibodies Ltd (IPA) via the Vested app. You can start investing in Immunoprecise Antibodies Ltd (IPA) with a minimum investment of $1.
You can invest in shares of Immunoprecise Antibodies Ltd (IPA) via Vested in three simple steps:
The 52-week high price of Immunoprecise Antibodies Ltd (IPA) is $2.6. The 52-week low price of Immunoprecise Antibodies Ltd (IPA) is $0.32.
The price-to-earnings (P/E) ratio of Immunoprecise Antibodies Ltd (IPA) is
The price-to-book (P/B) ratio of Immunoprecise Antibodies Ltd (IPA) is 0.50
The dividend yield of Immunoprecise Antibodies Ltd (IPA) is 0.00%
The market capitalization of Immunoprecise Antibodies Ltd (IPA) is $12.10M
The stock symbol (or ticker) of Immunoprecise Antibodies Ltd is IPA